| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/16/1997 | US5668291 Thiosubstituted pyridines, treatment of aids and hiv |
| 09/16/1997 | US5668284 Cephalosporin derivatives |
| 09/16/1997 | US5668282 4,5-cyclicimidazo[1,5-A]quinoxalines |
| 09/16/1997 | US5668279 Treatment of central nervous system diorders and gastrointestinal disorders |
| 09/16/1997 | US5668269 3'-(2')-amimo- or thiol-modified, fluorescent dye-coupled nucleosides, nucleotides and oligonucleotides |
| 09/16/1997 | US5668182 Method of calming or sedating an animal with a hydroxy benzaldehyde compound |
| 09/16/1997 | US5668181 Use of the R-enantiomers of N-propargyl-1-aminoindan compounds for the treatment of depression |
| 09/16/1997 | US5668180 Alkoxyaryl compounds |
| 09/16/1997 | US5668178 Viricide, bactericide, hiv |
| 09/16/1997 | US5668177 Method of treating wrinkles using tartaric acid |
| 09/16/1997 | US5668175 Use of selective ligands for treatment of disease states responsive to steroid or steroid-like retinoids |
| 09/16/1997 | US5668174 Gamma-linolenic acid or dihomo-g-linolenic acid |
| 09/16/1997 | US5668173 Method of increasing the conversion of homocysteine to methionine and uses thereof |
| 09/16/1997 | US5668172 Anthraquinone pharmaceutical compounds and uses therefor |
| 09/16/1997 | US5668171 Halogenated mevalonate compositions and uses thereof in ras-dependent cell growth |
| 09/16/1997 | US5668168 1,2-dithiin antiinfective agents |
| 09/16/1997 | US5668167 Treatment of pneumocystis pneumonia with carbazole derivatives |
| 09/16/1997 | US5668166 Methods of inhibiting pneumocystis carinii pneumonia and compounds useful therefor |
| 09/16/1997 | US5668165 Small molecule inhibition of RNA/ligand binding |
| 09/16/1997 | US5668162 Isothiazolones lower plasma levels of lipoprotein(a) |
| 09/16/1997 | US5668161 Substituted thiazoles for the treatment of inflammation |
| 09/16/1997 | US5668157 Cyanoguanidines as K-channel blockers |
| 09/16/1997 | US5668156 Di (aromatic) compounds and their use in human and veterinary medicine and in cosmetics |
| 09/16/1997 | US5668155 Administration of pirenzepine, methyl scopolamine and other muscarinic receptor antagonists for treatment of lipid metabolism disorders |
| 09/16/1997 | US5668152 Protein kinase C inhibitors |
| 09/16/1997 | US5668151 Useful as anorexigenic agents in promoting weight loss and treating eating disorders |
| 09/16/1997 | US5668150 Antiallergy, antiinflammatory |
| 09/16/1997 | US5668149 Administering chloroquine or salt |
| 09/16/1997 | US5668148 Benign prostatic hypertrophy |
| 09/16/1997 | US5668144 Muscarinic agents |
| 09/16/1997 | US5668143 Heterocyclic benzenesulfonylimine derivatives as inhibitors of IL-1 action |
| 09/16/1997 | US5668142 Tetracyclic piperidine and 1,4-oxazine compounds |
| 09/16/1997 | US5668139 Xanthine derivatives |
| 09/16/1997 | US5668138 Affinity for sigma receptors, central nervous system disorders |
| 09/16/1997 | US5668137 N-heterocyclic sulfonamides having endothelin receptor activity |
| 09/16/1997 | US5668136 Trisubstituted benzene derivatives, composition and methods of treatment |
| 09/16/1997 | US5668134 Method for preventing or reducing photosensitivity and/or phototoxicity reactions to medications |
| 09/16/1997 | US5668133 Ophthalmic compositions comprising emedastine and methods for their use |
| 09/16/1997 | US5668132 HIV Protease inhibitors useful for the treatment of AIDS |
| 09/16/1997 | US5668131 Controlling helicobacter bacteria |
| 09/16/1997 | US5668130 Medicament for treating gastrointestinal disorders |
| 09/16/1997 | US5668129 N-substituted azaheterocyclic carboxylic acids and esters thereof |
| 09/16/1997 | US5668127 Nitroimidazole antibacterial compounds and methods of use thereof |
| 09/16/1997 | US5668126 Bile acid derivatives, processes for their preparation, and use as pharmaceuticals |
| 09/16/1997 | US5668125 Spironolactone |
| 09/16/1997 | US5668124 Use of aldosterone antagonists to inhibit myocardial fibrosis |
| 09/16/1997 | US5668123 Method of maintaining remission from venous ulcers with sulphasalazine and its metabolite |
| 09/16/1997 | US5668122 Inhibition of cell migration |
| 09/16/1997 | US5668120 Iontophoretic delivery of bisphosphonates to the alveolar bone |
| 09/16/1997 | US5668119 Topical pharmaceutical containing heparin and method of treatment |
| 09/16/1997 | US5668118 Method of synthesis of 2-O-desulfated Heparin and use thereof for inhibition of elastase and Cathepspin G |
| 09/16/1997 | US5668117 Nervous system disorders using aromatic acid compounds |
| 09/16/1997 | US5668115 Hydrolyzates of colominic acid |
| 09/16/1997 | US5668114 NADH and NADPH pharmaceuticals for treating hypertension |
| 09/16/1997 | US5668113 Method of using 1,5-anhydrohexitol nucleoside analogues to treat viral infections |
| 09/16/1997 | US5667981 Diagnostics and treatments for cancers expressing tyrosine phosphorylated CRKL protein |
| 09/16/1997 | US5667975 Method of fluorescent detection of nucleic acids and cytoskeleton elements using bis-dicationic aryl furans |
| 09/16/1997 | US5667825 Treatment and prevention of iron-deficiency anemia |
| 09/16/1997 | US5667810 Method of accelerating the healing of bone and cartilage tissue with cytokines |
| 09/16/1997 | US5667808 Metal ion complex |
| 09/16/1997 | US5667807 Thermal granulation process |
| 09/16/1997 | US5667805 Morphine therapy |
| 09/16/1997 | US5667800 Lotions with lipids and emulsifiers |
| 09/16/1997 | US5667799 Method for treating headache pain with topical local anesthetic compositions |
| 09/16/1997 | US5667794 Heartburn treatment |
| 09/16/1997 | US5667789 Emulsifier free, cosmetic and dermatological compositions, treatment of acne, aging |
| 09/16/1997 | US5667784 Tocols as adjuvant in vaccine |
| 09/16/1997 | US5667775 Phosphate-binding polymers for oral administration |
| 09/16/1997 | US5667774 Crosslinked polymeric ammonium salts |
| 09/16/1997 | US5667765 Photoprotective/cosmetic compositions comprising at least one solid organic sunscreen compound and salicylate solvents therefor |
| 09/16/1997 | CA2170250C Preparation of omeprazole and lansoprazole and intermediates useful therein |
| 09/16/1997 | CA2166483C New pharmaceutical formulation |
| 09/16/1997 | CA2000830C 0-(3-amino-2-hydroxypropyl)-hydroximic acid halides and process for preparing the same |
| 09/15/1997 | CA2199889A1 Use of naphthalene derivatives in treating lung carcinoma |
| 09/15/1997 | CA2199888A1 Method for improving morbidity and/or mortality |
| 09/14/1997 | CA2199756A1 Methods for cell mobilization using in vivo treatment with hyaluronan (ha) |
| 09/13/1997 | CA2199771A1 Aminoalkyl and acylaminoalkyl ethers, process for their preparation, and their use as bradykinin receptor antagonists |
| 09/12/1997 | WO1997033174A1 Selectively n-alkylated peptidomimetic combinatorial libraries and compounds therein |
| 09/12/1997 | WO1997032998A2 Materials and methods relating to the identification of a polymorphism associated with disease susceptibility |
| 09/12/1997 | WO1997032996A1 Direct molecular diagnosis of friedreich ataxia |
| 09/12/1997 | WO1997032994A1 Method for inhibiting adenylosuccinate synthetase activity methylthioadenosine phosphorylase deficient cells |
| 09/12/1997 | WO1997032992A1 Immortalized hematopoietic cell lines, cell system thereof with stromal cells, in vitro, ex vivo and in vivo uses, and in vitro generation of dendritic cells and macrophages |
| 09/12/1997 | WO1997032989A2 Recombinant aav vector-based transduction system and use of same |
| 09/12/1997 | WO1997032988A1 Adeno-associated virus vector for boosting immunogenicity of cells |
| 09/12/1997 | WO1997032983A1 Recombinant live feline immunodeficiency virus and proviral dna vaccines |
| 09/12/1997 | WO1997032979A1 Inhibition of proliferation of cells |
| 09/12/1997 | WO1997032973A1 Combinations of fungal cell wall degrading enzyme and fungal cell membrane affecting compound |
| 09/12/1997 | WO1997032909A1 Betaine polymers, process for producing the same, and antiviral agents |
| 09/12/1997 | WO1997032895A1 Methods of alleviating neuropathic pain using prosaposin-derived peptides |
| 09/12/1997 | WO1997032889A1 MURINE α(1,3)FUCOSYLTRANSFERASE Fuc-TVII, DNA ENCODING THE SAME, METHOD FOR PREPARING THE SAME, ANTIBODIES RECOGNIZING THE SAME, IMMUNOASSAYS FOR DETECTING THE SAME, PLASMIDS CONTAINING SUCH DNA, AND CELLS CONTAINING SUCH A PLASMID |
| 09/12/1997 | WO1997032887A1 Oligonucleotide analogues |
| 09/12/1997 | WO1997032884A1 Meso-substituted tripyrrane compounds, compositions, and methods for making and using the same |
| 09/12/1997 | WO1997032883A1 Azolobenzazepine derivatives as neurologically active agents |
| 09/12/1997 | WO1997032882A1 PYRIMIDO[5,4-d]PYRIMIDINES, MEDICAMENTS CONTAINING THESE COMPOUNDS, THEIR USE AND PROCESS FOR THEIR PRODUCTION |
| 09/12/1997 | WO1997032881A1 4-amino pyrimidine derivates, medicaments containing these compounds, their use and process for their production |
| 09/12/1997 | WO1997032880A1 Pyrimido[5,4-d]pyrimidines, medicaments containing these compounds, their use and process for their production |
| 09/12/1997 | WO1997032874A1 Novel sulphur derivatives comprising an amide bond, method for preparing same, use thereof as drugs, and pharmaceutical compositions containing such derivatives |
| 09/12/1997 | WO1997032873A1 Quinoxalinediones |
| 09/12/1997 | WO1997032872A1 Compounds with a sulfamate group |
| 09/12/1997 | WO1997032871A1 Tricyclic compounds, their production and use |